Calidi Biotherapeutics
CLDI----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Calidi Biotherapeutics(CLDI) the EBIT is -4.187 M (+17.29%);the EPS is -0.429 (+80.6%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B17.29%
----
----
EPS
-0.428580.60%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf